ПРЕРЫВИСТАЯ КАТЕТЕРИЗАЦИЯ МОЧЕВОГО ПУЗЫРЯ КАК «ЗОЛОТОЙ СТАНДАРТ» ЛЕЧЕНИЯ НЕЙРОГЕННОГО МОЧЕВОГО ПУЗЫРЯ У ЛИЦ, С ПОВРЕЖДЕНИЕМ СПИННОГО МОЗГА
2024 year | Issue: 2 | Pages: 148-157
АНАЛИЗ ОПЫТА МЕДСЕСТЕР И ФАКТОРОВ, ВЛИЯЮЩИХ НА ДОБРОВОЛЬНОЕ СООБЩЕНИЕ ОБ ИНЦИДЕНТАХ
2024 year | Issue: 2 | Pages: 201-211
GASTRODUODENAL ULCERAL BLEEDINGS, DIAGNOSIS AND RISK FACTORS FOR REDUCTION. LITERATURE REVIEW.
2024 year | Issue: 2 | Pages: 135-143
РАНЕВЫЕ ПОКРЫТИЯ НА ОСНОВЕ БИОПОЛИМЕРОВ, ИСПОЛЬЗУЕМЫЕ ДЛЯ ЗАЖИВЛЕНИЯ РАН. ОБЗОР ЛИТЕРАТУРЫ.
2024 year | Issue: 2 | Pages: 121-134
ЖҰМСАҚ ТІНДЕРДІҢ ІРІҢДІ ЖАРАЛАРЫН ЕМДЕУДЕ «ВОКАДИН» ЕРІТІНДІСІН ҚОЛДАНУДЫҢ ТИІМДІЛІГІ
2012 year | Issue: 4 | Pages: 50-52
III ДӘРЕЖЕДЕГІ АРТЕРИАЛЬДЫ ГИПЕРТЕНЗИЯМЕН НАУҚАСТАРДЫ ЕМДЕУДІҢ ТИІМДІЛІГІН БАҒАЛАУ
2012 year | Issue: 4 | Pages: 48-50
СОЗЫЛМАЛЫ ЖУРЕК ЖЕТІСПЕУШІЛІГІ БАР НАУҚАСТАРДА ЖҮРЕК РЕСИНХРОНИЗАЦИЯЛЫҚ ТЕРАПИЯСЫНЫҢ ТИІМДІЛІГІН БАҒАЛАУ
2012 year | Issue: 4 | Pages: 43-47
БЕСҚАРАҒАЙ АУДАНЫНЫҢ ТҰРҒЫНДАРЫНЫҢ ЖӘНЕ ОЛАРДЫҢ ҰРПАҚТАРЫНЫҢ АРАСЫНДА СӘУЛЕЛЕНУДЕН КЕЙІНГІ АУРУЛАРДЫҢ ТАРАЛУЫ
2012 year | Issue: 4 | Pages: 38-42
СӘУЛЕЛЕНГЕН АТА-АНАДАН ТУЫЛҒАН ҰРПАҚТАР ТОПТАРЫНДАҒЫ ВЕГЕТАТИВТІК ГОМЕОСТАТТЫҢ ЖАҒДАЙЫ
2012 year | Issue: 4 | Pages: 35-38
CALCIUM CHANNELS BLOCKERS - A ROLE IN MODERN THERAPY OF CARDIOVASCULAR DISEASES: IN FOCUS – DILTIAZEM
Calcium channels blockers – group of the drugs which basic property is ability to brake a calcium current inside of smooth muscle cells through the special channels named “slow calcium channels”. Diltiazem Lannacher renders cardioprotective action with antioxidative effect, angioprotective action, antiagregant action, antiatherogenous action, nephroprotective action, cerebroprotective action.
More
2012 year | Issue: 2 | Pages: 24-34
DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AT TREATMENT OF ARTERIAL HYPERTENSION: LERKAMEN
Arterial hypertension (AH) is independent risk factor of myocardial infarction, brain stroke, chronic heart failure (CHF) and hypertensive nephropathy, death from cardiovascular diseases.
Main aim of therapy of AH is maximal decreasing of risk of development of cardiovascular morbidity and mortality.
This lecture includes data about pharmacodynamics and therapeutic efficiency of dihydropyridine calcium channel blocker Lerkamen, its advantages, indications and contraindications, metabolic neutrality, organ protection.
More
Main aim of therapy of AH is maximal decreasing of risk of development of cardiovascular morbidity and mortality.
This lecture includes data about pharmacodynamics and therapeutic efficiency of dihydropyridine calcium channel blocker Lerkamen, its advantages, indications and contraindications, metabolic neutrality, organ protection.
More
2012 year | Issue: 2 | Pages: 18-24
ORGANIZATION OF CARE FOR THE PEOPLE AT MGA "MSU FOR ELDERLY AND GENERAL TYPE WITH DISABLED" SEMEY SITI
In connection with the sudden changes in the demographic structure of the society, it will be actual to implement the nursing process in different health institutions of the Republic of Kazakhstan. The main purpose of this research was a creation of ways for optimization of care model for residents of "Health care establishment for elderly and disabled persons of general type" of the Semey city on the basis of the complex examination results. The project has been carried out through the work of the scientific and practical Nursing School.
More
2012 year | Issue: 2 | Pages: 15-17
THE ROLE OF A DOCTOR IN THE RELATIONSHIPS WITH PATIENTS
In order to implement the basic principles of a healthcare reform to achieve quality and efficiency of medical care provided to patients is necessary to ensure the unity of the doctor and the patient. These theoretical principles could be realized by the creation of «Schools of Health».
More
2012 year | Issue: 2 | Pages: 13-15
ORGANIZATIONAL AND METHODOLOGICAL ASPECTS OF CARDIOVASCULAR MORTALITY RATE REGISTRATION
This article describes the results of the study on cardiovascular mortality rate in primary care. More than 80% of the pop-ulation dies from cardiovascular disease in the lack of medical care. The problems an accurate statement of cardiovascular mortality rate registration and solutions are given.
More
2012 year | Issue: 2 | Pages: 10-12